Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
188.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (5.405%)
Market Cap: £99.47m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

AGM Statement

28 Jun 2011 07:00

RNS Number : 2153J
Somero Enterprises Inc.
28 June 2011
 

Press Announcement

28 June 2011

Somero Enterprises, Inc ®

('Somero' or 'the Company')

AGM statement

At Somero's annual general meeting to be held later today Larry Horsch, Somero's chairman, will make the following statement on the Company's development and on current trading.

 

2010 was an important year for Somero. Steady progress on cost control and sales execution resulted in the first increase in EBITDA since 2007. In addition, the strong open relationship with our bankers enabled the Company to amend and extend its loan facility out until July 2013. This has enabled management to focus on implementation of Somero's strategic plan, successfully introduce new products into the market and maximize opportunities from investments in emerging markets.

 

Market conditions in 2011 have continued to present opportunities as well as challenges. There have been encouraging trends in the build up of customer enquiries and spare parts sales, indicating an important increase in the overall level of usage of Somero's machines by our customers. The economic environment in North America and in Europe, however, means that there are still delays in converting sales of new machines, especially at the larger end of our product range. This, together with the stronger relative sales performance in our refurbished products, has led to lower gross margins than expected, but management expect this to recover going forward.

 

Management continue to deliver exceptional focus on every available sales opportunity, whilst retaining a very tight control on costs. With overall market conditions remaining tough and ongoing volatility on a month-by-month basis, Somero is taking the precautionary measure of a further cost restructuring process, which is expected to reduce overall group costs by $0.4m in 2011 and circa $1m in each full year thereafter.

 

We look forward to reporting on Somero's development at the time of our Interim results this autumn and continue to position the Company to benefit from the recovery in our markets when it comes.

Enquiries

Somero Enterprises, Inc

Jack Cooney / Mike Niemela

+00 1 239 210 6507

Hawkpoint Partners Limited

Chris Robinson / Serge Rissi

+44 (0) 20 7665 4500

Collins Stewart Europe Limited

Piers Coombs

+44 (0) 20 7523 8000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUBSNRAVANUAR
Date   Source Headline
18th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Nov 20253:12 pmRNSHolding(s) in Company
14th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Nov 20252:13 pmRNSTransaction in Own Shares and Total Voting Rights
11th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Oct 20257:00 amRNSHolding(s) in Company
14th Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Oct 20254:50 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Sep 20256:01 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20257:00 amRNSHolding(s) in Company
16th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20254:28 pmRNSHolding(s) in Company
10th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Aug 20257:01 amRNSTransaction in Own Shares and Total Voting Rights
18th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20257:00 amRNSNotice of Results and Investor Presentation
8th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20257:00 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20257:00 amRNSTrading Update
23rd Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Jul 20257:00 amRNSHolding(s) in Company
17th Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Jun 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Jun 20254:16 pmRNSResult of AGM
17th Jun 20257:50 amRNSAGM Statement
6th Jun 20255:29 pmRNSHolding(s) in Company
6th Jun 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
21st May 20252:19 pmRNSRestricted Stock Units, Director/PDMR Shareholding
12th May 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th May 20257:00 amRNSRestricted Stock Units, Director/PDMR Shareholding
1st May 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20257:00 amRNSAnnual Report and Notice of AGM
30th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Apr 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.